Leidos Jumps On Q1 Beat As Defense, Tech Demand Fuel Growth, 2025 Outlook Reaffirmed

Benzinga
07 May

Leidos Holdings Inc (NYSE:LDOS) reported first-quarter fiscal 2025 results on Tuesday. The company reported a quarterly revenue growth of 7% year-over-year to $4.25 billion, beating the analyst consensus estimate of $4.10 billion. The stock price gained after the report.

Also Read: Leidos Q4 Earnings: $7.6 Billion In Net Bookings, CEO Highlights Business Momentum And 2025 Outlook

Revenues grew year-over-year due to increased demand across all customer segments, with three of the four reporting segments growing 7% or more.

The defense, aviation, information technology and biomedical research, the company's adjusted EPS was $2.97, up 30% Y/Y, beating the analyst consensus estimate of $2.50.

Adjusted net income was $391 million for the quarter, up 25% Y/Y.

Adjusted EBITDA was $601 million, up 23% Y/Y. The margin of 14.2% increased from 12.3% a year ago. 

Net bookings totaled $2.1 billion for the quarter, representing a book-to-bill ratio of 0.5. As a result, the backlog at the end of the year was $46.3 billion, of which $7.3 billion was funded. 

Leidos held $842 million in cash and equivalents as of April 4, 2025.

Outlook: Leidos reiterated fiscal 2025 revenue of $16.9 billion–$17.3 billion. The analyst consensus stands at $17.13 billion.

The company expects its fiscal 2024 adjusted EPS of $10.35–$10.75 versus the $10.68 consensus estimate.

LDOS Price Action: Leidos Holding stock is up 4.29% at $154.28 at publication on Tuesday.

Read Next:

  • Mastercard Lifts Annual Outlook After Q1 Beat, Fueled By Cross-Border Surge

Photo: JHVEPhoto via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10